This upregulation, in turn, increases the expression of the downstream target gene nuclear receptor subfamily 2 group F member 1 (NR2F1), thereby promoting cell proliferation, invasion, inflammatory responses, and tumor angiogenesis. The gene discussed is NR2F1; the disease is neoplasm.